[go: up one dir, main page]

CN104561152B - It is a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes - Google Patents

It is a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes Download PDF

Info

Publication number
CN104561152B
CN104561152B CN201510003451.5A CN201510003451A CN104561152B CN 104561152 B CN104561152 B CN 104561152B CN 201510003451 A CN201510003451 A CN 201510003451A CN 104561152 B CN104561152 B CN 104561152B
Authority
CN
China
Prior art keywords
lipase
decarboxylation
fatty acids
fatty
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510003451.5A
Other languages
Chinese (zh)
Other versions
CN104561152A (en
Inventor
阎金勇
李盛英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Institute of Bioenergy and Bioprocess Technology of CAS
Original Assignee
Qingdao Institute of Bioenergy and Bioprocess Technology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Institute of Bioenergy and Bioprocess Technology of CAS filed Critical Qingdao Institute of Bioenergy and Bioprocess Technology of CAS
Priority to CN201510003451.5A priority Critical patent/CN104561152B/en
Publication of CN104561152A publication Critical patent/CN104561152A/en
Application granted granted Critical
Publication of CN104561152B publication Critical patent/CN104561152B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6418Fatty acids by hydrolysis of fatty acid esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明属于生物工程与能源技术领域中脂肪烯烃的生物制备方法,具体说是一种基于脂肪酶与P450脂肪酸脱羧酶偶联催化的脂肪烯烃催化合成的方法。以甘油酯作为原料,通过脂肪酶水解和P450脱羧的偶联催化,即脂肪酶水解甘油酯生成游离脂肪酸,生成的脂肪酸再经过P450脱羧产生脂肪烯烃。本发明的脂肪酶与P450脂肪酸脱羧酶介导的体外偶联生物催化过程,仅需两步酶促催化步骤,反应条件与酶比例容易调控,底物转化率高,能耗低,无污染,是一种过程可控、成本低廉的脂肪烯烃新兴绿色催化系统,具有很好的应用前景。The invention belongs to the biological preparation method of aliphatic olefins in the field of bioengineering and energy technology, and specifically relates to a method for catalyzing the synthesis of aliphatic olefins based on the coupling catalysis of lipase and P450 fatty acid decarboxylase. Glycerides are used as raw materials to catalyze the coupling of lipase hydrolysis and P450 decarboxylation, that is, lipase hydrolyzes glycerides to generate free fatty acids, and the generated fatty acids are decarboxylated by P450 to generate aliphatic olefins. The in vitro coupling biocatalysis process mediated by lipase and P450 fatty acid decarboxylase of the present invention only needs two steps of enzymatic catalysis, the reaction conditions and enzyme ratio are easy to control, the substrate conversion rate is high, the energy consumption is low, and there is no pollution. It is an emerging green catalytic system for aliphatic olefins with controllable process and low cost, and has a good application prospect.

Description

一种基于脂肪酶与P450脂肪酸脱羧酶偶联催化的脂肪烯烃催 化合成的方法A kind of aliphatic olefin catalyst based on the coupling catalysis of lipase and P450 fatty acid decarboxylase Synthetic method

技术领域technical field

本发明属于生物工程与能源技术领域中脂肪烯烃的生物制备方法,具体说是一种基于脂肪酶与P450脂肪酸脱羧酶偶联催化的脂肪烯烃催化合成的方法。The invention belongs to the biological preparation method of aliphatic olefins in the field of bioengineering and energy technology, and specifically relates to a method for catalyzing the synthesis of aliphatic olefins based on the coupling catalysis of lipase and P450 fatty acid decarboxylase.

背景技术Background technique

随着石油等传统化石能源的不断消耗,能源安全战略及环境保护等问题的日益突出,世界各国都在积极尝试以可再生生物资源为原料生产生物燃料和化学品。以短链醇、脂肪酸甲酯(乙酯)、脂肪烃(包括烯烃和烷烃)等为代表的传统和新型先进生物液体燃料,正吸引着越来越多的关注。在生物燃料方面,燃料乙醇和以脂肪酸甲酯(乙酯)为代表的第一代生物柴油的开发相对成熟,但均存在各自的不足。燃料乙醇作为汽油的替代品,存在水溶性高,挥发性强,能量密度低等缺点。与短链醇燃料(如乙醇)和第一代生物柴油脂肪酸甲酯(乙酯)相比,作为先进生物燃料(Advanced biofuels)的脂肪烃结构和性质更接近于石化柴油,具有能量密度高,吸湿性低,燃烧效率高等优越特性,可以作为汽油、柴油及航空燃料的替代品或添加剂。因此,脂肪烃催化合成途径研究成为先进生物燃料研究领域一大热点。With the continuous consumption of traditional fossil energy such as petroleum, and the increasingly prominent issues of energy security strategy and environmental protection, countries all over the world are actively trying to produce biofuels and chemicals from renewable biological resources. Traditional and new advanced bio-liquid fuels, represented by short-chain alcohols, fatty acid methyl esters (ethyl esters), aliphatic hydrocarbons (including olefins and alkanes), etc., are attracting more and more attention. In terms of biofuels, the development of fuel ethanol and the first generation of biodiesel represented by fatty acid methyl ester (ethyl ester) is relatively mature, but both have their own shortcomings. As a substitute for gasoline, fuel ethanol has the disadvantages of high water solubility, strong volatility, and low energy density. Compared with short-chain alcohol fuels (such as ethanol) and first-generation biodiesel fatty acid methyl esters (ethyl esters), the structure and properties of aliphatic hydrocarbons as advanced biofuels (Advanced biofuels) are closer to petrochemical diesel, with high energy density, With low hygroscopicity and high combustion efficiency, it can be used as a substitute or additive for gasoline, diesel and aviation fuel. Therefore, the research on the catalytic synthesis pathway of aliphatic hydrocarbons has become a hot spot in the field of advanced biofuel research.

目前脂肪烃的制备主要依赖于高温(250-450℃)高压(20-70bar)条件下铂钯等贵金属催化剂介导的氢化化学工艺。与传统的化工工艺相比,生物催化与合成具有高效,能耗低,环保等优点。截至目前,已陆续报导一些脂肪烃生物合成途径:At present, the preparation of aliphatic hydrocarbons mainly relies on the hydrogenation chemical process mediated by noble metal catalysts such as platinum and palladium under the conditions of high temperature (250-450°C) and high pressure (20-70bar). Compared with traditional chemical processes, biocatalysis and synthesis have the advantages of high efficiency, low energy consumption, and environmental protection. Up to now, some aliphatic hydrocarbon biosynthetic pathways have been reported successively:

(1)2010年,美国LS9生物能源公司的Schirmer等鉴定了蓝细菌Synechococcuselongates PCC 7942的脂酰-ACP还原酶和脂肪醛脱羰基酶将脂酰-ACP转化为脂肪烷烃或脂肪烯烃的生物合成途径。(1) In 2010, Schirmer et al. of LS9 Bioenergy Company in the United States identified the biosynthetic pathway of fatty acyl-ACP reductase and fatty aldehyde decarbonylase in cyanobacteria Synechococcuselongates PCC 7942 to convert fatty acyl-ACP into fatty alkanes or fatty alkenes .

(2)2010年,Bel ler等鉴定了细菌Micrococcus luteus ATCC 4698中基于OleA酶催化脱羧缩合反应的长链烯烃生物合成途径,能将脂酰-CoA通过脱羧缩合,酮基加氢还原,羟基脱水等一系列生化反应生成含有内部双键的脂肪烯烃。(2) In 2010, Beller et al. identified a long-chain olefin biosynthesis pathway based on OleA enzyme-catalyzed decarboxylation condensation reaction in the bacterium Micrococcus luteus ATCC 4698, which can decarboxylate fatty acyl-CoA, reduce ketone group hydrogenation, and dehydrate hydroxyl groups A series of biochemical reactions produce aliphatic olefins containing internal double bonds.

(3)2011年,Pfleger等鉴定了基于蓝细菌Synechococcus sp.PCC 7002Ols聚酮合成酶产生带末端双键的脂肪烯烃生物合成途径。长链脂肪酸酰基载体蛋白ACP1通过酮基合成酶、酰基转移酶、酮基还原酶、磺基转移酶及硫酯酶催化的一系列生化反应生成具有末端双键的脂肪烯烃。(3) In 2011, Pfleger et al. identified a biosynthetic pathway for aliphatic olefins with terminal double bonds based on the polyketide synthase of cyanobacteria Synechococcus sp. PCC 7002Ols. The long-chain fatty acid acyl carrier protein ACP1 generates fatty alkenes with terminal double bonds through a series of biochemical reactions catalyzed by ketosynthase, acyltransferase, ketoreductase, sulfotransferase and thioesterase.

(4)2011年,LS9公司Rude等报导了基于细菌Jeotagalicoccus sp.ATCC 8456中细胞色素P450脱羧酶(OleTJE)催化脂肪酸脱羧生成烯烃的反应。该P450(OleTJE)在辅因子过氧化氢(H2O2)存在的条件下将脂肪酸通过脱羧反应生成具有末端双键的脂肪烯烃。(4) In 2011, Rude et al. from LS9 Company reported the reaction of cytochrome P450 decarboxylase (OleT JE ) in bacterium Jeotagalicoccus sp.ATCC 8456 to catalyze the decarboxylation of fatty acids to form alkenes. The P450 (OleT JE ) decarboxylates fatty acids to aliphatic olefins with terminal double bonds in the presence of the cofactor hydrogen peroxide (H 2 O 2 ).

(5)2013年,Akhtar等构建了由硫酯酶、羧酸还原酶及脂肪醛脱羰基酶组成的脂肪烃生物合成途径,将脂酰-ACP转化为脂肪烃。(5) In 2013, Akhtar et al. constructed an aliphatic hydrocarbon biosynthetic pathway consisting of thioesterase, carboxylic acid reductase and fatty aldehyde decarbonylase to convert fatty acyl-ACP into aliphatic hydrocarbons.

生物燃料的开发虽然解决了原料可再生和环保等问题,但成本居高不下是制约其工业规模化生产的最主要瓶颈之一。这些成本包括原料成本、催化剂成本和生产过程成本,其中原料成本尤为关键。上述已报导的脂肪烃生物合成途径大多是基于脂肪酸代谢途径,以游离的脂肪酸(Free fatty acid)或者是脂酰化的脂肪酸形式(脂酰-ACP或脂酰-CoA)为直接原料。脂肪酸从头合成(De novo biosynthesis)涉及多步酶促反应组成的代谢网络,起始底物(糖等)转化脂肪酸的利用率较低。过表达脂肪酸合成途径中的关键酶基因和敲除脂肪酸氧化途径中的关键酶基因等代谢工程(Metabolic engineering)手段虽然在一定程度上可提高脂肪酸的积累量,但由于脂肪酸代谢调控网络的精密性与复杂性,通过过表达脂肪酸代谢途径中较多的关键酶会增加宿主细胞的代谢负担,同时通过遗传改造来强化脂肪酸合成会增加脂肪酸代谢网络的不可控因素。全面系统地认识、利用并改造脂肪酸代谢网络难度较大,使脂肪酸积累量进一步提升的空间有限。因此基于脂肪酸代谢途径,以脂肪酸为直接原料生产脂肪烯烃的成本过高,制约了其产业化应用。Although the development of biofuels has solved the problems of renewable raw materials and environmental protection, the high cost is one of the most important bottlenecks restricting its industrial scale production. These costs include raw material cost, catalyst cost and production process cost, among which raw material cost is particularly critical. Most of the reported aliphatic hydrocarbon biosynthetic pathways are based on fatty acid metabolism pathways, using free fatty acid (Free fatty acid) or fatty acid acylated fatty acid form (acyl-ACP or acyl-CoA) as the direct raw material. De novo fatty acid synthesis (De novo biosynthesis) involves a metabolic network composed of multi-step enzymatic reactions, and the utilization rate of initial substrates (sugar, etc.) into fatty acids is low. Metabolic engineering methods such as overexpression of key enzyme genes in the fatty acid synthesis pathway and knockout of key enzyme genes in the fatty acid oxidation pathway can increase the accumulation of fatty acids to a certain extent, but due to the precision of the regulatory network of fatty acid metabolism With the complexity, overexpression of more key enzymes in the fatty acid metabolic pathway will increase the metabolic burden of the host cell, while enhancing fatty acid synthesis through genetic modification will increase the uncontrollable factors of the fatty acid metabolic network. It is difficult to comprehensively and systematically understand, utilize and transform fatty acid metabolic network, and there is limited room for further improvement of fatty acid accumulation. Therefore, based on the pathway of fatty acid metabolism, the cost of producing aliphatic olefins from fatty acids as direct raw materials is too high, which restricts its industrial application.

脂肪酶(Lipase)作为典型的羧酸水解酶,能够催化天然底物甘油脂水解,生成游离的脂肪酸和甘油。甘油酯广泛存在于自然界中的动植物油脂和微生物油脂中,资源丰富,价格相对于游离脂肪酸更加低廉。经检索,以甘油酯为原料,基于酶催化的脂肪烃催化合成方法尚未见任何报导。Lipase, as a typical carboxylic acid hydrolase, can catalyze the hydrolysis of natural substrate glycerolipids to generate free fatty acids and glycerol. Glycerides are widely found in animal and vegetable oils and microbial oils in nature. They are rich in resources and cheaper than free fatty acids. After retrieval, there is no report on the catalytic synthesis method of aliphatic hydrocarbons based on enzyme catalysis using glyceride as raw material.

发明内容Contents of the invention

本发明的目的在于提供一种基于脂肪酶与P450脂肪酸脱羧酶偶联催化的脂肪烯烃催化合成的方法The object of the present invention is to provide a method for the catalytic synthesis of aliphatic olefins based on lipase and P450 fatty acid decarboxylase coupling catalysis

为实现上述目的本发明采用的技术方案为:The technical scheme that the present invention adopts for realizing the above object is:

一种基于脂肪酶与P450脂肪酸脱羧酶偶联催化的脂肪烯烃催化合成的方法,以甘油酯作为原料,通过脂肪酶水解和P450脱羧的偶联催化,即脂肪酶水解甘油酯生成游离脂肪酸,生成的脂肪酸再经过P450脱羧产生脂肪烯烃。A method for the catalytic synthesis of fatty olefins based on the coupling catalysis of lipase and P450 fatty acid decarboxylase, using glycerides as raw materials, through the coupling catalysis of lipase hydrolysis and P450 decarboxylation, that is, lipase hydrolyzes glycerides to generate free fatty acids, and generates The fatty acids are then decarboxylated by P450 to produce aliphatic olefins.

进一步的说是,以外源添加的油脂为底物,以外源供给的过氧化氢为辅因子,在催化剂的作用下于20-50℃条件下反应0.5-48h,偶联催化制备脂肪烯烃;Furthermore, the oil added from an external source is used as a substrate, and the hydrogen peroxide supplied from an external source is used as a cofactor, and is reacted at 20-50°C for 0.5-48 hours under the action of a catalyst, and aliphatic olefins are prepared by coupling catalysis;

所述催化剂为重组表达的脂肪酶和P450脂肪酸脱羧酶的生长态细胞培养液、重组表达的脂肪酶和P450脂肪酸脱羧酶的静息态全细胞或重组表达的脂肪酶和P450脂肪酸脱羧酶的无细胞粗提液或重组表达的脂肪酶和P450脂肪酸脱羧酶的纯酶。The catalyst is the growth state cell culture fluid of recombinantly expressed lipase and P450 fatty acid decarboxylase, the quiescent whole cell of recombinantly expressed lipase and P450 fatty acid decarboxylase or the absence of recombinantly expressed lipase and P450 fatty acid decarboxylase. Pure enzymes of crude cell extract or recombinantly expressed lipase and P450 fatty acid decarboxylase.

更进一步的说,以浓度为0.2-100mM油脂作为底物、浓度为0.2-300mM的过氧化氢(0.3%,v/v)作为辅因子,在催化剂的作用下偶联催化反应在pH为4-12的缓冲液体系下反应,反应后加入与反应物等体积含有内标的乙酸乙酯或正己烷萃取分析,油脂转化为脂肪烯烃的转化率为10-85%;Furthermore, with a concentration of 0.2-100mM oil as a substrate and a concentration of 0.2-300mM hydrogen peroxide (0.3%, v/v) as a cofactor, the coupling catalytic reaction under the action of a catalyst is at pH 4 React under the buffer system of -12. After the reaction, add ethyl acetate or n-hexane with an internal standard equal to the volume of the reactant for extraction and analysis. The conversion rate of oil into aliphatic olefins is 10-85%;

所述催化剂中脂肪酶与P450脂肪酸脱羧酶摩尔比为1:100-100:1。The molar ratio of lipase to P450 fatty acid decarboxylase in the catalyst is 1:100-100:1.

所述油酯为动植物来源的油脂、微生物来源的油脂或含高酸价的废弃油脂;The oils and esters are animal and plant derived oils, microbial derived oils or waste oils with high acid value;

所述脂肪酶为对油酯具有水解作用的脂肪酶;The lipase is a lipase that hydrolyzes oils and esters;

所述P450脂肪酸脱羧酶为对脂肪酸具有脱羧活性的酶。The P450 fatty acid decarboxylase is an enzyme with decarboxylation activity on fatty acids.

所述油酯为大豆油、菜籽油、玉米油、棉籽油、微藻油、酵母源油脂、鱼油,或地沟油;The oil ester is soybean oil, rapeseed oil, corn oil, cottonseed oil, microalgae oil, yeast oil, fish oil, or waste oil;

所述脂肪酶为疏绵状嗜热丝孢菌(Thermomyces lanuginosus)脂肪酶Tl l、黑曲霉(Aspergillus niger)脂肪酶、白地霉(Geotrichum candidum)脂肪酶、皱褶假丝酵母(Candida rugosa)脂肪酶、南极假丝酵母(Candida antarctica)脂肪酶、米曲霉(Aspergillus oryzae)脂肪酶、米根霉(Rhizopus oryzae)脂肪酶、解脂耶氏酵母(Yarrowia lipolylica)脂肪酶、米赫毛霉(Mucor miehe)脂肪酶、粘质沙雷氏菌(Serratiamarcescens)脂肪酶、假单胞菌属(Pseudomonas sp.)脂肪酶或芽孢杆菌属(Bacillus sp.)脂肪酶;The lipase is Thermomyces lanuginosus lipase T11, Aspergillus niger lipase, Geotrichum candidum lipase, Candida rugosa lipase Enzymes, Candida antarctica lipase, Aspergillus oryzae lipase, Rhizopus oryzae lipase, Yarrowia lipolytica lipase, Mucor miehe) lipase, Serratia marcescens lipase, Pseudomonas sp. lipase or Bacillus sp. lipase;

所述P450脂肪酸脱羧酶为源于Jeotgalicoccus sp.)的OleTJE或来源于Bacillussubtilis的P450BSβThe P450 fatty acid decarboxylase is OleT JE derived from Jeotgalicoccus sp.) or P450 BSβ derived from Bacillus subtilis.

所述催化剂按如下方式获得:The catalyst is obtained as follows:

1)通过构建含有目的脂肪酶基因的重组质粒,转化重组质粒至大肠杆菌感受态细胞,获得表达脂肪酶与P450脂肪酸脱羧酶的重组大肠杆菌基因工程菌株;获得的大肠杆菌基因工程菌株作为出发菌株通过两阶段发酵;1) By constructing a recombinant plasmid containing the target lipase gene, transforming the recombinant plasmid into Escherichia coli competent cells, obtaining a recombinant Escherichia coli genetically engineered strain expressing lipase and P450 fatty acid decarboxylase; the obtained Escherichia coli genetically engineered strain is used as the starting strain through two-stage fermentation;

2)上述发酵液即为生长态细胞培养液作为催化剂;2) The above-mentioned fermented liquid is the growth state cell culture liquid as a catalyst;

上述发酵液通过离心分离收集过表达脂肪酶与P450脂肪酸脱羧酶的重组大肠杆菌细胞,即为静息态全细胞作为催化剂;The above fermentation broth is centrifuged to collect recombinant Escherichia coli cells overexpressing lipase and P450 fatty acid decarboxylase, that is, resting whole cells are used as catalysts;

上述发酵液经超声破碎细胞,获得脂肪酶与P450脂肪酸脱羧酶的无细胞粗提液作为催化剂;The above fermentation liquid is ultrasonically disrupted to obtain a cell-free crude extract of lipase and P450 fatty acid decarboxylase as a catalyst;

或,上述发酵液利用重组酶His-tag与Ni-NTA的亲和层析所得纯酶作为催化剂。Alternatively, the above fermented broth uses the pure enzyme obtained by affinity chromatography of the recombinant enzyme His-tag and Ni-NTA as a catalyst.

上述采用诱导型质粒分别与脂肪酶或P450脂肪酸脱羧酶通过酶切与酶连的方式分别构建的重组质粒,然后将分别获得的重组质粒转化大肠杆菌感受态细胞,分别获得构建的高效表达脂肪酶或P450脂肪酸脱羧酶的基因工程菌;The above-mentioned recombinant plasmids were respectively constructed by using inducible plasmids and lipase or P450 fatty acid decarboxylase by enzyme digestion and enzyme ligation, and then the respectively obtained recombinant plasmids were transformed into Escherichia coli competent cells to obtain the constructed high-efficiency lipase Or P450 fatty acid decarboxylase genetically engineered bacteria;

将上述获得的基因工程菌通过诱导前的菌体生物量积累,直至菌体密度达到OD600=0.6-0.8,而后经IPTG诱导的酶表达的两阶段发酵,并保持菌体的进一步生长。The genetically engineered bacteria obtained above are accumulated by the biomass of the bacteria before induction until the density of the bacteria reaches OD 600 =0.6-0.8, and then subjected to two-stage fermentation of enzyme expression induced by IPTG, and the further growth of the bacteria is maintained.

所述的诱导型质粒为受T7启动子控制的pET质粒系列;如pRSFDuet1或pET28b或pET22b,所述的大肠杆菌为Escherichia coli BL21(DE3)。The inducible plasmid is a pET plasmid series controlled by T7 promoter; such as pRSFDuet1 or pET28b or pET22b, and the Escherichia coli is Escherichia coli BL21 (DE3).

将上述获得的工程菌分别在LB培养基中以200-250rpm的转速震荡下于37℃培养至过夜,过夜后继续在37℃的温度下,将培养液按照1-3(v/v)%的接种量在LB培养基中以200-250rpm的转速震荡下培养至菌体密度达到OD600=0.6-0.8;而后向培养基中加入0.1-1mM IPTG于18-20℃,诱导表达时间为18-20h,即分别获得不同工程菌的发酵液;The engineered bacteria obtained above were respectively cultured in LB medium at 37°C under shaking at a speed of 200-250rpm until overnight, and continued at a temperature of 37°C after overnight, and the culture solution was mixed with 1-3 (v/v)% The inoculum amount was cultured in LB medium under shaking at 200-250rpm until the cell density reached OD 600 =0.6-0.8; then 0.1-1mM IPTG was added to the medium at 18-20°C, and the induction time was 18 -20h, that is, to obtain the fermentation broth of different engineering bacteria respectively;

所述工程菌为脂肪酶基因工程菌发酵培养的LB培养基中加入25-100μg/ml稳定质粒所需的抗生素;The engineering bacterium is the antibiotic required for the stable plasmid of 25-100 μg/ml added to the LB medium of the lipase gene engineering bacterium fermentation culture;

所述工程菌为P450脂肪酸脱羧酶的基因工程菌发酵培养的LB培养基中加入25-100μg/ml稳定质粒所需的抗生素和1mM维生素B12。The engineering bacterium is P450 fatty acid decarboxylase genetically engineered bacterium fermented and cultured by adding 25-100 μg/ml of antibiotics required for stable plasmids and 1 mM vitamin B12.

所述稳定质粒所需的抗生素根据质粒不同为氨苄青霉素、卡那霉素、氯霉素或链霉素。The antibiotics required for the stable plasmid are ampicillin, kanamycin, chloramphenicol or streptomycin according to different plasmids.

本发明所具有优点:The present invention has advantages:

本发明以廉价易得的甘油酯作为原料,通过脂肪酶水解和P450脱羧酶的偶联催化脂肪烯烃合成的方法,相对于脂肪烃的传统氢化化学工艺与从头生物合成途径,仅需两步酶促催化步骤,反应条件与酶比例容易调控,底物转化率高,能耗低,无污染,是一种过程可控、成本低廉的脂肪烯烃新兴绿色催化系统,具有很好的应用前景。The present invention uses cheap and easy-to-obtain glycerides as raw materials to catalyze the synthesis of aliphatic olefins through the coupling of lipase hydrolysis and P450 decarboxylase. Compared with the traditional hydrogenation chemical process and de novo biosynthesis pathway of aliphatic hydrocarbons, only two enzyme steps are required The catalyst-promoting step, the reaction conditions and the ratio of enzymes are easy to adjust, the conversion rate of the substrate is high, the energy consumption is low, and there is no pollution.

具体实施方式Detailed ways

下面结合实施例对本发明做进一步说明。The present invention will be further described below in conjunction with embodiment.

实施例1Example 1

本实施例脂肪酶与P450脂肪酸脱羧酶偶联催化制备脂肪烯烃的方法是:The method for the preparation of fatty olefins catalyzed by the coupling of lipase and P450 fatty acid decarboxylase in this embodiment is:

(1)基因工程菌的构建:通过酶切与酶连的方式将pRSFDuet1质粒分别与疏绵状嗜热丝孢菌(Thermomyces lanuginosus)脂肪酶Tl l基因或来源于Jeotgalicoccus sp.的OleTJE基因构建重组质粒,所得转化重组质粒至大肠杆菌感受态细胞Escherichia coliBL21(DE3),采用含有50μg/ml卡那霉素的LB抗性平板筛选阳性转化子,分别获得高效表达脂肪酶或P450脂肪酸脱羧酶的重组大肠杆菌基因工程菌株。(1) Construction of genetically engineered bacteria: the pRSFDuet1 plasmid was constructed with the lipase Tl l gene of Thermomyces lanuginosus or the OleT JE gene derived from Jeotgalicoccus sp. Recombinant plasmids, the resulting recombinant plasmids were transformed into Escherichia coli competent cells Escherichia coliBL21 (DE3), positive transformants were screened using LB resistance plates containing 50 μg/ml kanamycin, and high-expression lipase or P450 fatty acid decarboxylase were obtained respectively. Recombinant Escherichia coli genetically engineered strains.

(2)脂肪酶与P450脂肪酸脱羧酶纯酶的制备:将上述筛选的重组基因工程菌株单菌落接种至装有20ml LB培养基的250ml摇瓶中,于摇床转速250rpm,37℃培养过夜,按照1%(v/v)接种量将过夜种子液接种至装有500ml LB的2L摇瓶中,于37℃,250rpm摇床培养,待菌体密度达到OD600=0.6-0.8时,加入0.2mM IPTG,于20℃启动酶诱导表达,并保持菌体的进一步生长直至20h。(2) Preparation of lipase and P450 fatty acid decarboxylase pure enzyme: inoculate the single bacterium colony of the recombinant genetically engineered strain of above-mentioned screening into the 250ml shaking flask that 20ml LB medium is housed, in shaker speed 250rpm, cultivate overnight at 37°C, According to the inoculum amount of 1% (v/v), inoculate the overnight seed solution into a 2L shaker flask with 500ml LB, and cultivate it on a shaking table at 37°C and 250rpm. When the cell density reaches OD 600 =0.6-0.8, add 0.2 mM IPTG, start the enzyme-induced expression at 20°C, and keep the further growth of the bacteria until 20h.

所述工程菌为脂肪酶基因工程菌发酵培养的LB培养基中加入50μg/ml卡那霉素;The engineering bacterium is added 50 μg/ml kanamycin to the LB medium fermented by lipase genetically engineered bacteria;

所述工程菌为P450脂肪酸脱羧酶的基因工程菌发酵培养的LB培养基中加入50μg/ml卡那霉素和1mM维生素B12。50 μg/ml kanamycin and 1 mM vitamin B12 were added to the LB medium for the fermentation culture of the genetic engineering bacteria of P450 fatty acid decarboxylase as the engineering bacteria.

将上述获得的发酵液通过离心分离分别收集胞内表达脂肪酶或P450脂肪酸脱羧酶的重组大肠杆菌细胞,而后超声破碎细胞,分别获得脂肪酶或P450脂肪酸脱羧酶的无细胞粗提液,分别获得的无细胞粗提液利用重组酶His-tag与Ni-NTA的亲和层析制备各自的纯酶,作为催化剂。Collect the recombinant Escherichia coli cells expressing lipase or P450 fatty acid decarboxylase in the cells by centrifugation, and then ultrasonically disrupt the cells to obtain cell-free crude extracts of lipase or P450 fatty acid decarboxylase, respectively. The cell-free crude extracts of the recombinant enzyme His-tag and Ni-NTA affinity chromatography were used to prepare the respective pure enzymes as catalysts.

(3)脂肪酶与P450脂肪酸脱羧酶偶联催化制备脂肪烯烃:以外源添加的0.5mM豆油为底物,以外源供给的1mM的0.3%过氧化氢(v/v)为辅因子,以上述所得纯酶作为催化剂,其中纯酶中纯化的脂肪酶为2μM,纯化的P450脂肪酸脱羧酶为4μM,反应介质为pH为7.8的磷酸盐缓冲液,30℃水浴条件下反应6h,通过脂肪酶介导的水解反应偶联P450脂肪酸脱羧酶介导的脱羧反应,制备脂肪烯烃。待偶联反应结束后,加入与反应体系等体积含有十七碳脂肪酸内标的乙酸乙酯萃取分析,采用内标法计算,豆油转化为脂肪烯烃(十五碳和十七碳烯烃)的转化率为31%。(3) Coupling of lipase and P450 fatty acid decarboxylase to catalyze the preparation of aliphatic olefins: 0.5mM soybean oil added by exogenous sources is used as substrate, 0.3% hydrogen peroxide (v/v) of 1mM supplied by exogenous sources is used as cofactor, with the above The obtained pure enzyme is used as a catalyst, wherein the purified lipase in the pure enzyme is 2 μM, the purified P450 fatty acid decarboxylase is 4 μM, and the reaction medium is a phosphate buffer solution with a pH of 7.8, reacted for 6 hours at 30° C. in a water bath, and passed through the lipase-mediated Guided hydrolysis coupled with P450 fatty acid decarboxylase-mediated decarboxylation to produce aliphatic olefins. After the coupling reaction is finished, add ethyl acetate containing the internal standard of seventeen-carbon fatty acid in the same volume as the reaction system for extraction and analysis, and calculate the conversion rate of soybean oil into fatty olefins (pentadecene and heptadecene) by using the internal standard method was 31%.

实施例2Example 2

本实施例脂肪酶与P450脂肪酸脱羧酶偶联催化制备脂肪烯烃的方法是:The method for the preparation of fatty olefins catalyzed by the coupling of lipase and P450 fatty acid decarboxylase in this embodiment is:

(1)基因工程菌的构建:通过酶切酶连pRSFDuet1质粒与疏绵状嗜热丝孢菌(Thermomyces lanuginosus)脂肪酶Tl l基因或来源于Jeotgalicoccus sp.的OleTJE基因构建重组质粒,转化重组质粒至大肠杆菌感受态细胞Escherichia coli BL21(DE3),采用含有50μg/ml卡那霉素的LB抗性平板筛选阳性转化子,分别获得高效表达脂肪酶与P450脂肪酸脱羧酶的重组大肠杆菌基因工程菌株。(1) Construction of genetically engineered bacteria: construct a recombinant plasmid by combining pRSFDuet1 plasmid with Thermomyces lanuginosus lipase T1 l gene or OleT JE gene derived from Jeotgalicoccus sp., and transform the recombinant Transfer the plasmid to E. coli competent cells Escherichia coli BL21(DE3), use LB resistance plates containing 50 μg/ml kanamycin to screen positive transformants, and obtain recombinant E. coli genetic engineering that highly expresses lipase and P450 fatty acid decarboxylase respectively strain.

(2)脂肪酶与P450脂肪酸脱羧酶无细胞粗提液的制备:将上述筛选的重组基因工程菌株单菌落接种至装有20ml LB培养基的250ml摇瓶中,于摇床转速250rpm,37℃培养过夜,按照1%(v/v)接种量将过夜种子液接种至装有500ml LB的2L摇瓶中,于37℃,250rpm摇床培养,待菌体密度达到OD600=0.6-0.8时,加入0.2mM IPTG,于20℃启动酶诱导表达,并保持菌体的进一步生长直至20h。(2) Preparation of lipase and P450 fatty acid decarboxylase cell-free crude extract: Inoculate a single colony of the recombinant genetically engineered strains screened above into a 250ml shaker flask with 20ml LB medium, and shake at a rotating speed of 250rpm at 37°C Cultivate overnight, inoculate the overnight seed liquid into a 2L shaker flask filled with 500ml LB according to the inoculation amount of 1% (v/v), and culture on a shaker at 37°C and 250rpm until the cell density reaches OD 600 =0.6-0.8 , adding 0.2mM IPTG, starting the enzyme-induced expression at 20°C, and maintaining the further growth of the bacteria until 20h.

所述工程菌为脂肪酶基因工程菌发酵培养的LB培养基中加入50μg/ml卡那霉素;The engineering bacterium is added 50 μg/ml kanamycin to the LB medium fermented by lipase genetically engineered bacteria;

所述工程菌为P450脂肪酸脱羧酶的基因工程菌发酵培养的LB培养基中加入50μg/ml卡那霉素和1mM维生素B12。50 μg/ml kanamycin and 1 mM vitamin B12 were added to the LB medium for the fermentation culture of the genetic engineering bacteria of P450 fatty acid decarboxylase as the engineering bacteria.

将上述获得的发酵液通过离心分离分别收集胞内表达脂肪酶或P450脂肪酸脱羧酶的重组大肠杆菌细胞,即分别获得两种酶的静息态全细胞作为催化剂。Recombinant Escherichia coli cells expressing lipase or P450 fatty acid decarboxylase in the cells were collected by centrifuging the fermented broth obtained above, that is, the resting whole cells of the two enzymes were respectively obtained as catalysts.

(3)脂肪酶与P450脂肪酸脱羧酶偶联催化制备脂肪烯烃:以外源添加的微藻油(0.5mM)为底物,以外源供给的0.3%(v/v)过氧化氢(1.5mM)为辅因子,以静息态全细胞脂肪酶(20mg)与静息态全细胞P450脂肪酸脱羧酶(30mg)为混合催化剂,反应介质为pH为7.8的磷酸盐缓冲液,30℃水浴条件下反应12h,通过脂肪酶介导的水解反应偶联P450脂肪酸脱羧酶介导的脱羧反应,制备脂肪烯烃。待偶联反应结束后,加入等体积含有十七碳脂肪酸内标的乙酸乙酯萃取分析,采用内标法计算,微藻油转化为脂肪烯烃(十五碳和十七碳烯烃)的转化率为20%。(3) Coupling of lipase and P450 fatty acid decarboxylase to catalyze the preparation of aliphatic olefins: microalgae oil (0.5 mM) added by exogenous sources as substrate, 0.3% (v/v) hydrogen peroxide (1.5 mM) supplied by exogenous sources As a cofactor, resting state whole cell lipase (20mg) and resting state whole cell P450 fatty acid decarboxylase (30mg) are used as mixed catalysts, the reaction medium is phosphate buffer solution with a pH of 7.8, and the reaction is carried out in a water bath at 30°C 12h, aliphatic olefins were prepared by coupling lipase-mediated hydrolysis to P450 fatty acid decarboxylase-mediated decarboxylation. After the coupling reaction is finished, an equal volume of ethyl acetate containing an internal standard of seventeen carbon fatty acids is added for extraction analysis, and the internal standard method is used to calculate that the conversion rate of microalgae oil into aliphatic olefins (pentadecene and heptadecene) is 20%.

实施例3Example 3

(1)基因工程菌的构建:通过酶切酶连pRSFDuet1质粒与疏绵状嗜热丝孢菌(Thermomyces lanuginosus)脂肪酶Tl l基因片段构建pRSFDuet-tll重组质粒,酶切酶连pACYCDuet1质粒与来源于Jeotgalicoccus sp.的OleTJE基因片段构建重组质粒pACYCDuet-oleTJE,将两重组质粒共转化大肠杆菌感受态细胞Escherichia coli BL21(DE3),采用含有50μg/ml卡那霉素与25μg/ml氯霉素的LB抗性平板筛选阳性转化子,获得高效共表达脂肪酶与P450脂肪酸脱羧酶的重组大肠杆菌基因工程菌株。(1) Construction of genetically engineered bacteria: construct pRSFDuet-tll recombinant plasmid by connecting pRSFDuet1 plasmid with Thermomyces lanuginosus lipase T1 l gene fragment, and connect pACYCDuet1 plasmid with source The recombinant plasmid pACYCDuet-oleT JE was constructed from the OleT JE gene fragment of Jeotgalicoccus sp., and the two recombinant plasmids were co-transformed into E. coli competent cells Escherichia coli BL21 (DE3). Positive transformants were screened on the LB resistance plate of prime, and a recombinant Escherichia coli genetically engineered strain that efficiently co-expressed lipase and P450 fatty acid decarboxylase was obtained.

(2)脂肪酶与P450脂肪酸脱羧酶无细胞粗提液的制备:将上述筛选的重组基因工程菌株单菌落接种至装有20ml LB培养基的250ml摇瓶中,于摇床转速250rpm,37℃培养过夜,按照1%(v/v)接种量将过夜种子液接种至装有500ml LB的2L摇瓶中,于37℃,250rpm摇床培养,待菌体密度达到OD600=0.6-0.8时,加入0.2mM IPTG,于20℃启动酶诱导表达,并保持菌体的进一步生长直至20h。(2) Preparation of lipase and P450 fatty acid decarboxylase cell-free crude extract: Inoculate a single colony of the recombinant genetically engineered strains screened above into a 250ml shaker flask with 20ml LB medium, and shake at a rotating speed of 250rpm at 37°C Cultivate overnight, inoculate the overnight seed solution into a 2L shaker flask filled with 500ml LB according to 1% (v/v) inoculation amount, and culture on a shaker at 37°C and 250rpm until the cell density reaches OD 600 =0.6-0.8 , adding 0.2mM IPTG, starting the enzyme-induced expression at 20°C, and maintaining the further growth of the bacteria until 20h.

所述工程菌为脂肪酶基因工程菌发酵培养的LB培养基中加入50μg/ml卡那霉素与25μg/ml氯霉素;The engineering bacterium is lipase genetically engineered bacteria fermented in LB medium, adding 50 μg/ml kanamycin and 25 μg/ml chloramphenicol;

所述工程菌为P450脂肪酸脱羧酶的基因工程菌发酵培养的LB培养基中加入50μg/ml卡那霉素与25μg/ml氯霉素和1mM维生素B12。50 μg/ml kanamycin, 25 μg/ml chloramphenicol and 1 mM vitamin B12 were added to the LB medium for fermentation and culture of genetically engineered bacteria with P450 fatty acid decarboxylase as the engineering bacteria.

将上述获得的发酵液通过离心分离分别收集胞内表达脂肪酶或P450脂肪酸脱羧酶的重组大肠杆菌细胞,即分别获得两种酶的静息态全细胞作为催化剂。Recombinant Escherichia coli cells expressing lipase or P450 fatty acid decarboxylase in the cells were collected by centrifuging the fermented broth obtained above, that is, the resting whole cells of the two enzymes were respectively obtained as catalysts.

(3)脂肪酶与P450脂肪酸脱羧酶偶联催化制备脂肪烯烃:以外源添加的微藻油(0.5mM)为底物,以外源供给的0.3%(v/v)过氧化氢(1.5mM)为辅因子,以两种酶共表达的静息态全细胞(50mg)为催化剂,反应介质为pH为7.8的磷酸盐缓冲液,30℃水浴条件下反应12h,通过脂肪酶介导的水解反应偶联P450脂肪酸脱羧酶介导的脱羧反应,制备脂肪烯烃。待偶联反应结束后,加入等体积含有十七碳脂肪酸内标的乙酸乙酯萃取分析,采用内标法计算,微藻油转化为脂肪烯烃(十五碳和十七碳烯烃)的转化率为30%。(3) Coupling of lipase and P450 fatty acid decarboxylase to catalyze the preparation of aliphatic olefins: microalgae oil (0.5 mM) added by exogenous sources as substrate, 0.3% (v/v) hydrogen peroxide (1.5 mM) supplied by exogenous sources As a cofactor, the resting state whole cells (50mg) co-expressed by the two enzymes are used as the catalyst, the reaction medium is phosphate buffer solution with a pH of 7.8, and the reaction is carried out at 30°C for 12 hours in a water bath, and the hydrolysis reaction mediated by lipase Coupling of P450 Fatty Acid Decarboxylase-Mediated Decarboxylation to Produce Aliphatic Alkenes. After the coupling reaction is finished, an equal volume of ethyl acetate containing an internal standard of seventeen carbon fatty acids is added for extraction analysis, and the internal standard method is used to calculate that the conversion rate of microalgae oil into aliphatic olefins (pentadecene and heptadecene) is 30%.

实施例4Example 4

(1)基因工程菌的构建:通过酶切酶连pET22b质粒与疏绵状嗜热丝孢菌(Thermomyces lanuginosus)脂肪酶Tl l基因片段构建pET22b-tll重组质粒,酶切酶连pACYCDuet1质粒与来源于Jeotgalicoccus sp.的OleTJE基因片段构建重组质粒pACYCDuet-oleTJE,将两重组质粒共转化大肠杆菌感受态细胞Escherichia coli BL21(DE3),采用含有100μg/ml氨苄青霉素与25μg/ml氯霉素的LB抗性平板筛选阳性转化子,获得高效共表达脂肪酶与P450脂肪酸脱羧酶的重组大肠杆菌基因工程菌株。(1) Construction of genetically engineered bacteria: pET22b-tll recombinant plasmid was constructed by enzyme-digesting enzyme connecting pET22b plasmid and Thermomyces lanuginosus lipase T1 l gene fragment, and enzyme-digesting enzyme connecting pACYCDuet1 plasmid and source The recombinant plasmid pACYCDuet-oleT JE was constructed from the OleT JE gene fragment of Jeotgalicoccus sp., and the two recombinant plasmids were co-transformed into E. coli competent cells Escherichia coli BL21 (DE3). Positive transformants were screened on the LB resistance plate, and recombinant Escherichia coli genetically engineered strains that efficiently co-expressed lipase and P450 fatty acid decarboxylase were obtained.

(2)脂肪酶与P450脂肪酸脱羧酶无细胞粗提液的制备:将上述筛选的重组基因工程菌株单菌落接种至装有20ml LB培养基的250ml摇瓶中,于摇床转速250rpm,37℃培养过夜,按照1%(v/v)接种量将过夜种子液接种至装有500ml LB的2L摇瓶中,于37℃,250rpm摇床培养,待菌体密度达到OD600=0.6-0.8时,加入0.2mM IPTG,于20℃启动酶诱导表达,并保持菌体的进一步生长直至12h。(2) Preparation of lipase and P450 fatty acid decarboxylase cell-free crude extract: Inoculate a single colony of the recombinant genetically engineered strains screened above into a 250ml shaker flask with 20ml LB medium, and shake at a rotating speed of 250rpm at 37°C Cultivate overnight, inoculate the overnight seed solution into a 2L shaker flask filled with 500ml LB according to 1% (v/v) inoculation amount, and culture on a shaker at 37°C and 250rpm until the cell density reaches OD 600 =0.6-0.8 , adding 0.2mM IPTG, starting the enzyme-induced expression at 20°C, and maintaining the further growth of the bacteria until 12h.

所述工程菌为脂肪酶基因工程菌发酵培养的LB培养基中加入100μg/ml氨苄青霉素与25μg/ml氯霉素;100 μg/ml ampicillin and 25 μg/ml chloramphenicol were added to the LB medium for fermentation culture of lipase genetically engineered bacteria as described engineering bacteria;

所述工程菌为P450脂肪酸脱羧酶的基因工程菌发酵培养的LB培养基中加入100μg/ml氨苄青霉素与25μg/ml氯霉素和1mM维生素B12。100 μg/ml ampicillin, 25 μg/ml chloramphenicol and 1 mM vitamin B12 were added to the LB medium for fermentation and culture of genetically engineered bacteria with P450 fatty acid decarboxylase as the engineering bacteria.

将上述分别获得的共表达的生长态细胞培养液的发酵液,作为原位催化剂。The fermentation liquid of the co-expressed growing cell culture liquid obtained above is used as an in-situ catalyst.

(3)脂肪酶与P450脂肪酸脱羧酶偶联催化制备脂肪烯烃:以外源添加的橄榄油(0.5mM)为底物,以外源供给的0.3%(v/v)过氧化氢(1.5mM)为辅因子,以上述原位生长态细胞培养液为催化剂,28℃水浴条件下反应36h,通过脂肪酶介导的水解反应偶联P450脂肪酸脱羧酶介导的脱羧反应,制备脂肪烯烃。待偶联反应结束后,加入等体积含有十七碳脂肪酸内标的乙酸乙酯萃取分析,采用内标法计算,橄榄油转化为脂肪烯烃(十五碳和十七碳烯烃)的转化率为23%。(3) Coupling of lipase and P450 fatty acid decarboxylase to catalyze the preparation of aliphatic olefins: olive oil (0.5 mM) added from an external source was used as a substrate, and 0.3% (v/v) hydrogen peroxide (1.5 mM) supplied from an external source was used as The cofactor, using the above-mentioned in situ growth state cell culture medium as a catalyst, reacted in a water bath at 28°C for 36 hours, and prepared aliphatic olefins by coupling the hydrolysis reaction mediated by lipase to the decarboxylation reaction mediated by P450 fatty acid decarboxylase. After the coupling reaction is finished, an equal volume of ethyl acetate containing seventeen-carbon fatty acid internal standard is added for extraction analysis, and the internal standard method is used to calculate that the conversion rate of olive oil into aliphatic olefins (pentadecene and heptadecene) is 23 %.

Claims (10)

1. a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes, feature It is:Using glyceride as raw material, pass through coupling catalysed, the i.e. lipase hydrolysis glyceride life of lipase hydrolysis and P450 decarboxylations At free fatty, the aliphatic acid of generation generates fatty alkene using P450 decarboxylations.
2. the fatty olefin catalytic coupling catalysed with P450 decarboxylation of fatty acids enzymes based on lipase as described in claim 1 synthesizes Method, it is characterised in that:Using the grease of external source addition as substrate, using the hydrogen peroxide of external source supply as co-factor, it is being catalyzed 0.5-48h, the fatty alkene of coupling catalysed preparation are reacted under the action of agent under the conditions of 20-50 DEG C;
The catalyst is selected from the growth state cell culture fluid of the lipase and P450 decarboxylation of fatty acids enzymes of recombinant expression;Recombinate table The full cell of tranquillization state of the lipase and P450 decarboxylation of fatty acids enzymes that reach;The lipase and P450 decarboxylation of fatty acids enzymes of recombinant expression Acellular crude extract;One kind in the lipase of recombinant expression and the pure enzyme of P450 decarboxylation of fatty acids enzymes.
3. the fatty olefin catalytic coupling catalysed with P450 decarboxylation of fatty acids enzymes based on lipase as described in claim 2 synthesizes Method, it is characterised in that:Using 0.2-100mM greases as substrate, 0.2-300mM, the hydrogen peroxide that volumetric concentration is 0.3% Solution is reacted as co-factor, under the effect of the catalyst coupled catalytic reaction in the case where pH is the buffer solution system of 4-12, is reacted Ethyl acetate or n-hexane extraction containging interior traget are analyzed in equal volume with reactant for addition afterwards, and grease is converted into turning for fatty alkene Rate is 10-85%;
Lipase and P450 decarboxylation of fatty acids enzyme molar ratios are 1 in the catalyst:100-100:1.
4. by claim 1-3 any one of them based on lipase and the coupling catalysed fatty alkene of P450 decarboxylation of fatty acids enzymes The method catalyzed and synthesized, it is characterised in that:The grease is the grease of plant and animal material, microbe-derived grease or contains peracid The waste grease of valence;
The lipase is the lipase for having hydrolysis to grease.
5. the fatty olefin catalytic coupling catalysed with P450 decarboxylation of fatty acids enzymes based on lipase as described in claim 4 synthesizes Method, it is characterised in that:The grease is soybean oil, rapeseed oil, corn oil, cottonseed oil, microalgae oil, yeast source grease, fish Oil or gutter oil;
The lipase is Thermomyces lanuginosus(Thermomyces lanuginosus)Lipase Tll, aspergillus niger (Aspergillus niger)Lipase, geotrichum candidum(Geotrichum candidum)Lipase, fold candida (Candida rugosa)Lipase, antarctic candida(Candida antarctica)Lipase, aspergillus oryzae (Aspergillus oryzae)Lipase, Rhizopus oryzae(Rhizopus oryzae)Lipase, Yarrowia lipolytica (Yarrowia lipolylica)Lipase, conspicuous Mucor of rice(Mucor miehe)Lipase, serratia marcescens(Serratia marcescens)Lipase, pseudomonas(Pseudomonas sp.)Lipase or bacillus(Bacillus sp.) Lipase;
The P450 decarboxylation of fatty acids enzyme is the OleT derived from Jeotgalicoccus sp.JEOr derive from Bacillus The P450 of subtilisBSβ
6. by claim 1-3 any one of them based on lipase and the coupling catalysed fatty alkene of P450 decarboxylation of fatty acids enzymes The method catalyzed and synthesized, it is characterised in that:The catalyst obtains as follows:
1)By building the recombinant plasmid containing purposeful lipase gene Yu P450 decarboxylation of fatty acids enzyme genes respectively, will obtain respectively The recombinant plasmid transformed obtained obtains the weight of expression lipase and P450 decarboxylation of fatty acids enzymes respectively to competent escherichia coli cell Group Recombinant organism strain;The Recombinant organism strain of acquisition is fermented as starting strain by two benches;
2)Zymotic fluid is to grow state cell culture fluid as catalyst;
Zymotic fluid collects the recombinant Bacillus coli cells for being overexpressed lipase and P450 decarboxylation of fatty acids enzymes by centrifuging, i.e., It is the full cell of tranquillization state as catalyst;
Zymotic fluid obtains lipase with the acellular crude extract of P450 decarboxylation of fatty acids enzymes as catalysis through sonicated cells Agent;
Or, zymotic fluid is using pure enzyme obtained by the affinity chromatography of recombinase His-tag and Ni-NTA as catalyst.
7. the fatty olefin catalytic coupling catalysed with P450 decarboxylation of fatty acids enzymes based on lipase as described in claim 6 synthesizes Method, it is characterised in that:
It is built respectively by way of digestion and enzyme company with lipase or P450 decarboxylation of fatty acids enzyme respectively using inducible plasmid Recombinant plasmid, the recombinant plasmid transformed competent escherichia coli cell that then will be obtained respectively obtains the efficient of structure respectively Express the genetic engineering bacterium of lipase or P450 decarboxylation of fatty acids enzymes;
The genetic engineering bacterium of above-mentioned acquisition is accumulated by the Fungal biodiversity before induction, until cell density reaches OD600= 0.6-0.8, and after the two benches of the expression of enzymes through IPTG inductions ferment, and keep the further growth of thalline.
8. the fatty olefin catalytic coupling catalysed with P450 decarboxylation of fatty acids enzymes based on lipase as described in claim 7 synthesizes Method, it is characterised in that:
The inducible plasmid is the pET plasmid series controlled by T7 promoters;The Escherichia coli are Escherichia coli BL21 (DE3)。
9. the fatty olefin catalytic coupling catalysed with P450 decarboxylation of fatty acids enzymes based on lipase as described in claim 7 synthesizes Method, it is characterised in that:
In 37 DEG C of cultures to mistake under the engineering bacteria of above-mentioned acquisition is shaken in LB culture mediums with the rotating speed of 200-250rpm respectively Night, overnight after continue at a temperature of 37 DEG C, by culture solution according to the inoculum concentration of 1-3%v/v in LB culture mediums with 200- Lower culture to the cell density of rotating speed concussion of 250rpm reaches OD600=0.6-0.8;And 0.1-1mM is added in backward culture medium For IPTG in 18-20 DEG C, the induced expression time is 18-20h, i.e., obtains the zymotic fluid of different engineering bacterias respectively;
When the engineering bacteria is the genetic engineering bacterium of high efficient expression lipase, 25-100 μ are added in the LB culture mediums of fermented and cultured Antibiotic needed for g/ml stable plasmids;
When the engineering bacteria is the genetic engineering bacterium of P450 decarboxylation of fatty acids enzymes, 25-100 is added in the LB culture mediums of fermented and cultured Antibiotic needed for μ g/ml stable plasmids and 1mM vitamin B12s.
10. the fatty olefin catalytic coupling catalysed based on lipase and P450 decarboxylation of fatty acids enzymes as described in claim 9 closes At method, it is characterised in that:Antibiotic needed for the stable plasmid is ampicillin, kanamycins, chloramphenicol or chain Mycin.
CN201510003451.5A 2015-01-05 2015-01-05 It is a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes Expired - Fee Related CN104561152B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510003451.5A CN104561152B (en) 2015-01-05 2015-01-05 It is a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510003451.5A CN104561152B (en) 2015-01-05 2015-01-05 It is a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes

Publications (2)

Publication Number Publication Date
CN104561152A CN104561152A (en) 2015-04-29
CN104561152B true CN104561152B (en) 2018-07-13

Family

ID=53078229

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510003451.5A Expired - Fee Related CN104561152B (en) 2015-01-05 2015-01-05 It is a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes

Country Status (1)

Country Link
CN (1) CN104561152B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017001606A1 (en) * 2015-06-30 2017-01-05 Total Marketing Services PRODUCTION OF α-OLEFINS
CN107201356A (en) * 2016-03-17 2017-09-26 中国科学院青岛生物能源与过程研究所 Support the reduction chaperone combination of P450 decarboxylation of fatty acids enzymatic activitys and its apply
CN106318607B (en) * 2016-08-31 2020-03-17 中国科学院青岛生物能源与过程研究所 Preparation method and application of microalgae acidified oil
US10220378B2 (en) 2017-06-01 2019-03-05 Uchicago Argonne, Llc Semiconductor-metal nanoparticle hybrids with natural and artificial proton pump for hydrogen production
CN108467861B (en) * 2018-04-27 2021-10-22 扬州大学 Sequence, preparation method and application of OleT-BM3R, a biocatalyst for catalytic synthesis of linear alpha-olefins
CN112877347B (en) * 2021-01-28 2023-02-17 华南理工大学 Multi-enzyme complex and construction method and application thereof
CN113621657B (en) * 2021-07-27 2022-06-14 华南理工大学 A kind of cell-like multiphase emulsion photoenzyme system catalyzes the method of lipid hydrolysis and decarboxylation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143034B2 (en) * 2007-08-21 2012-03-27 Polytechnic Institute Of New York University Method for preparing long-chain hydroxyacids, diacids and oligomers and polymers thereof

Also Published As

Publication number Publication date
CN104561152A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
CN104561152B (en) It is a kind of based on lipase and the coupling catalysed fatty olefin catalytic synthetic method of P450 decarboxylation of fatty acids enzymes
Arora et al. Co-culturing of oleaginous microalgae and yeast: paradigm shift towards enhanced lipid productivity
Qin et al. Biodiesel production catalyzed by whole-cell lipase from Rhizopus chinensis
Seo et al. Enzyme/whole-cell biotransformation of plant oils, yeast derived oils, and microalgae fatty acid methyl esters into n-nonanoic acid, 9-hydroxynonanoic acid, and 1, 9-nonanedioic acid
Białkowska Strategies for efficient and economical 2, 3-butanediol production: new trends in this field
Lu A perspective: photosynthetic production of fatty acid-based biofuels in genetically engineered cyanobacteria
Liu et al. Biosynthesis of fatty acid-derived hydrocarbons: perspectives on enzymology and enzyme engineering
Bisen et al. Biodiesel production with special emphasis on lipase-catalyzed transesterification
US20120115195A1 (en) Product of fatty acid esters from biomass polymers
Saini et al. Advanced biofuel production and road to commercialization: An insight into bioconversion potential of Rhodosporidium sp.
Tan et al. Photosynthesis driven conversion of carbon dioxide to fatty alcohols and hydrocarbons in cyanobacteria
Lennen et al. Microbial production of fatty acid-derived fuels and chemicals
Koreti et al. A comprehensive review on oleaginous bacteria: an alternative source for biodiesel production
Cao et al. Increasing unsaturated fatty acid contents in Escherichia coli by coexpression of three different genes
Kumar et al. Bacterial production of fatty acid and biodiesel: opportunity and challenges
Fu et al. Hydrocarbons, the advanced biofuels produced by different organisms, the evidence that alkanes in petroleum can be renewable
Yan et al. Assembly of lipase and P450 fatty acid decarboxylase to constitute a novel biosynthetic pathway for production of 1-alkenes from renewable triacylglycerols and oils
Hassan et al. In situ hydrogen, acetone, butanol, ethanol and microdiesel production by Clostridium acetobutylicum ATCC 824 from oleaginous fungal biomass
Yao et al. Investigation of fermentation conditions of biodiesel by-products for high production of β-farnesene by an engineered Escherichia coli
Iyyappan et al. Production of biodiesel from Caulerpa racemosa oil using recombinant Pichia pastoris whole cell biocatalyst with double displayed over expression of Candida antartica lipase
Abd-Alla et al. Improvement of fungal lipids esterification process by bacterial lipase for biodiesel synthesis
Sun et al. Comparative study on stability of whole cells during biodiesel production in solvent-free system
Uthoff et al. Current state and perspectives of producing biodiesel‐like compounds by biotechnology
Yang et al. Microbial recycling of glycerol to biodiesel
Xu et al. Integrated production for biodiesel and 1, 3-propanediol with lipase-catalyzed transesterification and fermentation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180713

Termination date: 20210105